Skip to main content

Entocort EC News

Budesonide Yields Durable Reduction in eGFR for IgA Nephropathy

MONDAY, Aug. 21, 2023 – For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in...

Studies Explore Risks for Exposure to Antenatal Corticosteroids

WEDNESDAY, Aug. 9, 2023 – Exposure to antenatal corticosteroids is associated with serious infection in children and with increased short- and long-term adverse health outcomes, according to two...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Crohn's Disease, Crohn's Disease - Maintenance, Inflammatory Bowel Disease

Entocort EC patient information at Drugs.com